Standard BioTools Inc (NAS:LAB)
$ 2.4 -0.01 (-0.41%) Market Cap: 909.27 Mil Enterprise Value: 892.58 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 70/100

Fluidigm Corp at UBS Global Healthcare Conference (Virtual) Transcript

May 19, 2020 / 08:40PM GMT
Release Date Price: $4.68 (-4.29%)
Daniel Gregory Brennan
UBS Investment Bank, Research Division - Senior Equity Research Analyst of Healthcare Life Sciences

Good afternoon. Welcome to another session at the UBS Global Healthcare Conference in the 04:40 slot. Pleased to be joined with the senior executive team [from Fluidigm] I have with me on the phone or virtual presentation, Chris Linthwaite, President and CEO; Vikram Jog, Chief Financial Officer; Agnes Lee, Head of Investor Relations.

So please don't hesitate if you're on the webcast to shoot me a question. Looks like I've already got one coming through, which is interesting. But feel free to shoot them through, and hopefully, we can get to those questions as we proceed.

So with that, Chris, Vikram and Agnes, thanks for attending the conference, and thanks for presenting.

Stephen Christopher Linthwaite
Fluidigm Corporation - President, CEO & Director

You bet, Dan. Thanks, and thank you to UBS for including us in this May conference.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot